StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK)
Equities research analysts at StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Down 2.4 % Shares of Evoke Pharma stock opened at $4.41 on Tuesday. The […]
9 Jan 01:26 · The Cerbat Gem